GlaxoSmithKline Starts First Human Trials For Ebola Vaccine In Africa

“The trials are expedited and aim to achieve in months something that generally takes years. Even the trial setup period was just two months long, compared to the six months to one year time period it generally takes to start a vaccine trial. GSK is also starting production of 10,000 doses of its vaccines simultaneously with the trials from the funds provided by UK’s Wellcome Trust and other donor organizations. The rationale behind starting production before trial results is that if the vaccine is successful it can immediately be provided to health workers in the affected regions without any unnecessary delays.”

http://www.bidnessetc.com/27047-gsk-starts-first-human-trials-for-ebola-vaccine-in-africa/

Scan to Donate Bitcoin to Freedomwat.ch Staff
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin